𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Advanced or metastatic gastrointestinal stromal tumors: Systemic treatment options

✍ Scribed by Megan V. Caram; Scott M. Schuetze

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
102 KB
Volume
104
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Surgical options for localized and advan
Surgical options for localized and advanced gastrointestinal stromal tumors
✍ Timothy L. Frankel; Alfred E. Chang; Sandra L. Wong πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 236 KB

## Abstract The development of imitinab has led to a revolution in the management of gastrointestinal stromal tumors (GIST), but surgical resection remains the cornerstone of treatment for patients with localized disease. The principles to surgical treatment of GIST include careful handling of tiss

Systemic therapy for advanced gastrointe
Systemic therapy for advanced gastrointestinal stromal tumors: Beyond imatinib
✍ Edward J. Kim; Mark M. Zalupski πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 88 KB

## Abstract Progression on first‐line therapy with imatinib in gastrointestinal stromal tumors (GIST) is caused by either initial resistance or more often a secondary mutation in tyrosine kinases KIT or PDGFR. Therapies in development for imatinib‐resistant GIST include agents that target KIT/PDGFR